EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark ONCOSPIRE GENOMICS was filed as Word mark on 06/18/2013 at the European Union Intellectual Property Office.
It was registered as a trademark on 11/12/2013.
The current status of the mark is "Registration expired".
| Trademark form | Word mark |
| File reference | 011907821 |
| Application date | June 18, 2013 |
| Publication date | August 5, 2013 |
| Entry date | November 12, 2013 |
| Expiration date | June 18, 2023 |
Trademark owner
200 First Street SW
55905 Rochester
US
55905 Rochester
US
Trademark representatives
Avenue Louise 203
1050 Bruxelles
BE
goods and services
42
Medical and scientific research, development and laboratory services; consulting services in the field of research, development and testing; genetic research, development and testing services; genomic research, development and testing services; DNA collection, testing and analysis services; genetic testing for diagnostic purposes; genomic testing for diagnostic purposes; medical and scientific research, development and consulting in the field of oncology; medical and scientific research in the field of genetics and genetic engineering; medical and scientific research and consulting in the fields of genomics and generation sequencing; medical and scientific research in the field of cancer treatment and diagnosis; data collection for research purposes, namely, the collection, testing and research of patient molecular and/or genomic data; scientific clinical studies; retrieval and correlation of genomic data; design and development of cancer treatment therapies; conducting clinical and pre-clinical trials; diagnostic services in the field of molecular science, comparative genome analysis, DNA arrays and screening of nucleic acids; research and development of identification and treatment methods for hereditary factors leading to disease; identification of target molecules for cancer treatment; proteogenomic profiling; DNA-sequencing; drug target development, identification and design; genotyping; gene screening; gene isolation; gene expression analysis; gene mapping; gene analysis; biomarker discovery
44
Medical testing for diagnostic or treatment purposes in the field of cancer research; medical diagnostic testing, monitoring and reporting services; medical evaluation services; medical monitoring services; medical diagnostic, prognostic and theranostic screening and testing; collection and preservation of DNA; consulting services in the field of healthcare and cancer diagnoses; providing and website featuring health and healthcare information related to cancer research, testing and screening; genetic testing for medical purposes; providing information in the field of cancer prevention, screening, diagnosis and treatment
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| April 18, 2024 | Extension, Trade mark expired | ||
| April 28, 2021 | Change Representative, Published | ||
| July 18, 2018 | Change Representative, Published |
ID: 11011907821